scispace - formally typeset
Y

Yoshito Ikada

Researcher at Nara Medical University

Publications -  116
Citations -  6529

Yoshito Ikada is an academic researcher from Nara Medical University. The author has contributed to research in topics: Tissue engineering & Gelatin. The author has an hindex of 37, co-authored 115 publications receiving 5971 citations. Previous affiliations of Yoshito Ikada include Suzuka University of Medical Science & Saitama Medical University.

Papers
More filters
Journal ArticleDOI

Challenges in tissue engineering

TL;DR: A brief overview on the current tissue engineering is given, covering the fundamentals and applications, and some critical problems to be resolved for the advances of tissue engineering are addressed from the engineering point of view.
Journal ArticleDOI

Polymer surface with graft chains

TL;DR: A review of surface modification techniques for polymers with graft chains can be found in this paper, focusing on grafting methods as well as the structure and function of grafted surfaces.
Journal ArticleDOI

Transplantation of a tissue-engineered pulmonary artery.

TL;DR: To the Editor: Various vascular grafts are commonly used in the reconstruction of cardiovascular tissues, however, prosthetic or bioprosthetic materials lack growth potential and therefore in child...
Journal ArticleDOI

Properties and morphology of poly(L-lactide). 4. Effects of structural parameters on long-term hydrolysis of poly(L-lactide) in phosphate-buffered solution

TL;DR: In this article, a specific peak appeared at a low molecular weight around 1×10 4 in gel permeation chromatography spectra of hydrolyzed poly( l -lactide) (PLLA) film, irrespective of the thermal history of the PLLA film.
Journal ArticleDOI

Successful application of tissue engineered vascular autografts: clinical experience.

TL;DR: Results indicate that BMCs seeded onto a biodegradable scaffold to establish tissue-engineered vascular autografts (TEVAs) is an ideal strategy, and present strong evidence for the justification and validity of the protocol in clinical trials of tissue engineering.